CON
Concentra Group Holdings Parent, Inc.
NYSE · Healthcare · Medical - Equipment & Services · US
$34.38
−0.39%Year over year
Reported trailing growth
- Revenue
- +14.0%
- EBITDA
- +19.4%
- EBIT
- +18.9%
- EPS
- +31.4%
- Free cash flow
- +87.1%
- Operating cash flow
- +29.2%
Forward estimates
Based on analyst estimates
- Revenue
- +6.0%
- EBITDA
- +4.6%
- EPS
- +10.6%
Three-year CAGR
- Revenue
- +7.9%
- EBITDA
- +7.4%
- EBIT
- +9.0%
- Net income
- -0.1%
- EPS
- +1.7%
- Free cash flow
- -4.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026